← brief for 2026-08-11 · Slowing decline

Treatment outcomes and safety of telitacicept in reducing proteinuria and hematuria for refractory childhood IgA vasculitis nephritis

Key takeaways

This study looked at telitacicept, a newer drug, in children with a hard-to-treat kidney inflammation caused by IgA vasculitis. It reported less protein and blood in the urine, which are signs the kidney filter is under less strain. This was a small treatment study without a comparison group, so it shows a link, not firm proof the drug caused the improvement.

Who did this work

Yue Xi (Beijing Children’s Hospital) · Nan Zhou (Beijing Children’s Hospital) · Qiang Sun (Beijing Children’s Hospital) · Chen Ling (Beijing Children’s Hospital) · Ying Liang (Beijing Children’s Hospital) · Lei Lei (Beijing Children’s Hospital) · Dan Wu (Beijing Children’s Hospital) · Zeping Cao (Beijing Children’s Hospital) · Xin Mo (Beijing Children’s Hospital) · Zhi Chen (Beijing Children’s Hospital)

Source

Paper · OpenAlex, CKD concept sweep (DB seed + weekly delta) · 2026-08-08
https://doi.org/10.1186/s40001-026-04954-0